Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201

Showing 26-50 of 201 citing articles:

Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective
Stefano Sanduzzi Zamparelli, Alessandro Sanduzzi, Marialuisa Bocchino
Life (2025) Vol. 15, Iss. 1, pp. 113-113
Open Access
The effect of locomotive syndrome on the trajectory of sleep disturbance in geriatric oncology inpatients
Yuling Yang, Hui Su, Hui Jing Lu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study
Seohyun Kim, Jiwon Ryoo, Hyeong Jun Cho, et al.
Journal of Korean Medical Science (2025) Vol. 40
Open Access
COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
Philippe Buchy, Yves Buisson, Otávio Cintra, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 300-317
Open Access | Times Cited: 36
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors
Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 3, pp. 307-316
Open Access | Times Cited: 35
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports
Konstantinos G. Kyriakoulis, Αναστάσιος Κόλλιας, Ioannis Kyriakoulis, et al.
Current Vascular Pharmacology (2021) Vol. 20, Iss. 1, pp. 96-110
Closed Access | Times Cited: 33
Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
Xiaoming Wu, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Antoní Torres, Ana Motos, Catia Cillóniz, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 7, pp. 850-864
Open Access | Times Cited: 24
Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts
Y. Zhao, Zhun Yao, Song Xu, et al.
Journal of Intensive Medicine (2024) Vol. 4, Iss. 4, pp. 417-432
Open Access | Times Cited: 4
Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
David Montani, Laurent Savale, Antoine Beurnier, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 1, pp. 2101090-2101090
Open Access | Times Cited: 30
Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study
Irene Prediletto, Letizia D’Antoni, Paolo Carbonara, et al.
European Journal of Internal Medicine (2021) Vol. 92, pp. 48-54
Open Access | Times Cited: 30
Respiratory Complications after COVID-19
Issa Al-Jahdhami, Adhra Al‐Mawali, Sami M Bennji
Oman Medical Journal (2021) Vol. 37, Iss. 1, pp. e343-e343
Open Access | Times Cited: 30
Awake Prone Positioning, High-Flow Nasal Oxygen and Non-Invasive Ventilation as Non-Invasive Respiratory Strategies in COVID-19 Acute Respiratory Failure: A Systematic Review and Meta-Analysis
Benedikt Schmid, Mirko Griesel, Anna-Lena Fischer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 391-391
Open Access | Times Cited: 21
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group
Mathias W. Pletz, Andreas Vestergaard Jensen, Christina Bahrs, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 21
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
Stefania Bellino
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2844-2848
Open Access | Times Cited: 21
Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP
Sergi Martí, Anne‐Elie Carsin, Júlia Sampol, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Lessons learned and lessons missed: impact of the coronavirus disease 2019 (COVID-19) pandemic on all-cause mortality in 40 industrialised countries and US states prior to mass vaccination
Vasilis Kontis, James E. Bennett, Robbie M. Parks, et al.
Wellcome Open Research (2022) Vol. 6, pp. 279-279
Open Access | Times Cited: 18
Improvements throughout the Three Waves of COVID-19 Pandemic: Results from 4 Million Inhabitants of North-West Italy
Valeria Caramello, Alberto Catalano, Alessandra Macciotta, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4304-4304
Open Access | Times Cited: 18
Potential of Lactoferrin in the Treatment of Lung Diseases
Katarzyna Kaczyńska, Monika Jampolska, Piotr Wojciechowski, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 192-192
Open Access | Times Cited: 11
The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic
Stéliana Ghibu, Anca Maria Juncan, Luca Liviu Rus, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 18, pp. 9776-9776
Open Access | Times Cited: 25
Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID)
Abdiel Absalón‐Aguilar, Marina Rull‐Gabayet, Alfredo Pérez‐Fragoso, et al.
Journal of General Internal Medicine (2021) Vol. 37, Iss. 1, pp. 4-14
Open Access | Times Cited: 25
Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone
Carlos King Ho Wong, Kristy T. K. Lau, Ivan Chi Ho Au, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e499-e508
Open Access | Times Cited: 24
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
ERJ Open Research (2021) Vol. 7, Iss. 4, pp. 00411-2021
Open Access | Times Cited: 24
Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
Barbara Bonnesen, Jens‐Ulrik Stæhr Jensen, Klaus Nielsen, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2259-2259
Open Access | Times Cited: 24
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Megan Crichton, Pieter Goeminne, Krizia Tuand, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210171-210171
Open Access | Times Cited: 24

Scroll to top